Table 1.
Normoxia | OGD | N-C6 | OGD-C6 | |
---|---|---|---|---|
Claudin-3 | 1.00 ± 0.06 | 1.01 ± 0.11§ | 0.73 ± 0.05*# | 0.82 ± 0.07 |
Claudin-5 | 1.00 ± 0.01 | 0.65 ± 0.08*§ | 1.04 ± 0.04# | 0.55 ± 0.05*§ |
Claudin-12 | 1.00 ± 0.05 | 1.05 ± 0.05 | 1.02 ± 0.09 | 1.17 ± 0.09 |
Occludin | 1.00 ± 0.02 | 0.38 ± 0.04*§ | 1.08 ± 0.11# | 0.24 ± 0.02*#§ |
ZO-1 | 1.00 ± 0.05 | 0.74 ± 0.04*§ | 1.18 ± 0.11# | 0.67 ± 0.07*§ |
Normoxia, cerebEND cells 4 h normoxia; OGD, cerebEND cells 4 h OGD; N-C6, cerebEND cells 4 h normoxia with C6-medium; OGD-C6, cerebEND cells 4 h OGD with C6-OGD medium. Data are presented as means ± s.e.m. (n = 8–10). Statistical significance was labeled with
vs. normoxia,
significant vs. OGD,
significant to N-C6 (p < 0.05, two-sided student's t-test with same variances).